Merck’s 2.4% dividend yield looks steady, but its long-term appeal depends on whether its pipeline can offset Keytruda’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results